Related Experiment Video
Updated: Dec 20, 2025

Preparation of Acute Brain Slices Using an Optimized N-Methyl-D-glucamine Protective Recovery Method
Published on: February 26, 2018
Classics in Chemical Neuroscience: Baclofen.
Caitlin N Kent1,2, Charlotte Park1, Craig W Lindsley1,3,2,4
1Warren Center for Neuroscience Drug Discovery, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Baclofen is the only FDA-approved GABAB agonist, initially for spasticity. This review explores its history, pharmacology, and societal impact, including off-label uses for addiction treatment.
Area of Science:
- Neuroscience
- Pharmacology
- Chemical Neuroscience
Background:
- Baclofen is the sole FDA-approved GABAB agonist, developed as a brain-penetrant analog of GABA.
- Initially investigated for epilepsy, its potent muscle relaxant properties led to approval for spasticity treatment.
- Baclofen's FDA approval preceded the discovery of its receptor and full elucidation of its mechanism of action.
Purpose of the Study:
- To provide a comprehensive review of baclofen's >60-year legacy.
- To detail the history, pharmacology, synthesis, metabolism, and administration of baclofen.
- To examine the societal impact and off-label applications of baclofen, particularly in addiction treatment.
Main Methods:
- Literature review of baclofen's historical development and scientific literature.
- Analysis of pharmacological data, including receptor interactions and mechanism of action.
- Examination of clinical applications, including approved and off-label uses.
Main Results:
- Baclofen's unique position as the only FDA-approved GABAB agonist is highlighted.
- Its efficacy in treating spasticity is well-established, stemming from its muscle relaxant properties.
- Emerging off-label uses, especially for alcohol and drug addiction, show significant therapeutic potential.
Conclusions:
- Baclofen remains a significant compound in chemical neuroscience with a rich history.
- Its multifaceted applications continue to expand beyond its initial indications.
- Further research into baclofen's mechanisms and applications holds promise for various neurological conditions and substance abuse disorders.
More Related Videos
Related Concept Videos
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Neurochemical Transmission: Sites of Drug Action

